Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Depreciation & Amortization (CF) (2017 - 2025)

Historic Depreciation & Amortization (CF) for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to $364699.0.

  • Selectis Health's Depreciation & Amortization (CF) fell 251.77% to $364699.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 1128.31%. This contributed to the annual value of $1.6 million for FY2024, which is 577.54% down from last year.
  • According to the latest figures from Q3 2025, Selectis Health's Depreciation & Amortization (CF) is $364699.0, which was down 251.77% from $362742.0 recorded in Q2 2025.
  • In the past 5 years, Selectis Health's Depreciation & Amortization (CF) registered a high of $453608.0 during Q3 2022, and its lowest value of $357868.0 during Q3 2023.
  • For the 5-year period, Selectis Health's Depreciation & Amortization (CF) averaged around $413306.3, with its median value being $430754.0 (2023).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 1820.97% in 2021, then tumbled by 2110.63% in 2023.
  • Selectis Health's Depreciation & Amortization (CF) (Quarter) stood at $447070.0 in 2021, then decreased by 0.64% to $444195.0 in 2022, then fell by 3.03% to $430754.0 in 2023, then fell by 15.79% to $362723.0 in 2024, then rose by 0.54% to $364699.0 in 2025.
  • Its last three reported values are $364699.0 in Q3 2025, $362742.0 for Q2 2025, and $363020.0 during Q1 2025.